CLDX vs LDOS · rev $37.0K vs P/E 16, rev $8.96B
Celldex Therapeutics Inc (CLDX) versus Leidos Holdings Inc (LDOS) — a side-by-side from cached financials, not a winner call.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
Latest reported LDOS revenue for 2026-07-03 was $8.96B. Net income was $682.0M. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
CLDX currently screens at market cap $2.35B. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Not investment advice. Open the CLDX and LDOS stock pages for the full models.
Not investment advice.